1. Rationale and design of the Children's Oncology Group (COG) study ALTE1621: a randomized, placebo-controlled trial to determine if low-dose carvedilol can prevent anthracycline-related left ventricular remodeling in childhood cancer survivors at high risk for developing heart failure. Issue 1 (December 2016) Authors: Armenian, Saro; Hudson, Melissa; Chen, Ming; Colan, Steven; Lindenfeld, Lanie; Mills, George; Siyahian, Aida; Gelehrter, Sarah; Dang, Ha; Hein, Wendy; Green, Daniel; Robison, Leslie; Wong, F.; Douglas, Pamela; Bhatia, Smita Journal: BMC cardiovascular disorders Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗